GT103
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for GT103, covering 2025-06-17 to 2026-03-11. Get the full timeline:
Most recent: Clinical Trial Update: GT103 in Combination With Pembrolizumab for the Treatment of Advanced or Metastatic STK11 Mutant Non-Small Cell Lung Cancer [Phase 2]